Is AI dictating patient care? What happens when your bank falls apart? And can Illumina endure some shareholder activism? We cover all that and more this week on the 250th episode of “The Readout LOUD,” […]
Illumina, the DNA sequencing giant whose stock has fallen 40% in two years, already had problems. Now it has to contend with Carl Icahn. The granddaddy of activist investors announced Monday morning that he’s taken […]
SAN DIEGO — The first time it happened, veteran real estate broker Ted Jacobs thought it was a fluke. But it didn’t take long for him to realize that the biotech industry’s demand for lab […]
Sanofi’s head of research and development, John Reed, is leaving the pharmaceutical giant to pursue a new opportunity, the company announced Monday. Reed joined Sanofi in 2018, after holding a similar position at Swiss pharma […]
Illumina, the largest maker of DNA sequencing technology, told investors exactly what they didn’t want to hear on Monday. For years, Illumina shares rose steadily as the company led the way on pushing down the […]
SAN DIEGO — Fate Therapeutics, a biotech upstart with big ambitions to use cell-based therapies to treat autoimmune diseases and cancer, is now planning to cut back on both jobs and experimental drugs after an […]
Biosplice’s bid to transform the treatment of everything from arthritis to cancer ran into a snag this week, with the San Diego biotech announcing that its experimental osteoarthritis drug failed to benefit patients in a […]
CARLSBAD, Calif. — Biotech companies developing cutting-edge cell and gene therapies often are tripped up by how much regulations around these drugs vary from country to country. On Wednesday, regulators from the United States, the […]
SAN DIEGO — After a steep drop in its stock price and with mounting competition from rivals, genomics giant Illumina on Thursday launched a new line of high-powered DNA sequencers, ratcheting up the race to […]
Is Illumina a victim of its own success? What makes the FDA change its mind? And how will petrodollars change biotech? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech […]
For Illumina, the leading maker of DNA sequencing equipment, there was bad news and worse news Tuesday. The bad news: The European Commission said it was blocking Illumina’s $8 billion acquisition of Grail, a firm […]
SAN DIEGO — Sequencing behemoth Illumina on Thursday won its case against the Federal Trade Commission in its bid to hold onto Grail, a Bay Area early cancer detection company that the genomics giant acquired […]
SAN DIEGO — From San Diego to New Jersey, biotechs developing new forms of birth control say they’re doubling down on those efforts after Roe v. Wade was overturned — even as the Supreme Court’s […]
SAN DIEGO — More than 40 years ago, Ivor Royston, a brash young assistant professor at University of California, San Diego, made an odd pitch to scientists and pharmaceutical executives across the country: Ditch your […]
Two months after being sued by Illumina over the alleged theft of trade secrets, Bay Area biotech Guardant Health fired back this week, rejecting the DNA sequencing giant’s claims and asking a federal judge to […]
DNA sequencing giant Illumina announced Thursday that it would enter the field of drug discovery, a major shift for a company that, since its founding in 1998, has thrived instead by selling picks and shovels […]
SAN DIEGO — Bay Area biotech Guardant Health is closer than ever to its ultimate goal — developing and deploying a simple, blood-based test that you could get during an annual doctor’s visit to spot […]
San Diego biotech Halozyme announced Wednesday that it plans to buy drug development and delivery firm Antares Pharma for about $960 million. The deal, expected to go through by the first half of this year, […]
If it wasn’t for a well-placed ad in the paper, Rob Perez might not have found his way to the life sciences industry. As he’ll tell you, he wasn’t on the traditional path to becoming […]
SAN DIEGO — If you’d seen him, you wouldn’t have known Scott Lippman was living through one of the most harrowing days of his 35-year career. The veteran oncologist, who directs UC San Diego’s Moores […]
DNA sequencing giant Illumina is suing Guardant Health, a firm that has become both its customer and rival, claiming that the patents at the core of Guardant’s quest to detect cancer with a simple blood […]
This is an optional event before SDBN Speed Networking February 3rd, attend both and you’ll learn and connect even more. Do you work in the area of protein degradation, or are you interested in learning […]
Do you work in the area of immuno-oncology? If so, join us for a group discussion about the current progress and challenges in the field, led by Eurofins Discovery lead scientists. Meet experts and local […]
Guest Author: Sudip Parikh, Senior Vice President & Managing Director, Americas at DIA Global* I had a great experience as a Scripps Research graduate student in La Jolla. After graduating, I moved to the east […]
Cambridge Healthtech Institute (CHI) organizes the annual Drug Discovery Chemistry (DDC) conference that focuses on drug discovery of small molecule candidates and challenges involved in their optimization. True to its motto ?Optimizing Small Molecules For […]
The 3rd Annual Society of Laboratory and Automation Screening Conference (SLAS2014) was held at the San Diego Convention Center on 1/18-22.? It was a reprieve for many as it was an escape from the polar […]
The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and […]
The biggest question in entrepreneurship is how does one take an idea and make it reality, make it something that?s tangible and positively affects an individual and society as a whole. This was the theme […]
San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, […]
Here at SDBN we?ve been updating our directory of 400+ San Diego biotech companies.? We were surprised to find close to 40 companies removed from the local scene ? due to acquisition or shut down.? […]
Copyright © 2023 Biotech Networks, LLC
